Drugs / intravenous immunoglobulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02954926 | Nov 2015 → Oct 2016 | neonatal sepsis | Hormozgan University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intravenous immunoglobulin | “intravenous immunoglobulin (IVIG) in prevention of preterm neonatal sepsis” NCT02954926 ↗ |
| Known as | IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02954926 ↗ |
| Modality | Protein / enzyme biologic | “intravenous immunoglobulin (IVIG)” NCT02954926 ↗ |
| Route | Intravenous | “intravenous immunoglobulin (IVIG)” NCT02954926 ↗ |